Vaccine Therapy Cluster

2009.04.18. AIDS: Therapeutic vaccine "in four or five years" says Montagnier in EP
Last year French Professor Luc Montagnier jointly won the Nobel Prize for Medicine with Françoise Barré-Sinoussi for their discovery of the HIV virus in 1983. On 1 April he took part in a conference on biomedical research organised by the European Parliament. In an exclusive interview we spoke to him about his hopes for a therapeutic vaccine for AIDS sufferers within "four or five years". He also spoke of his worries about a lack of interest in scientific research by young people. (Click here to continue...)

2008.12.06. Reuters - Nobel winner sees end to AIDS spread within years
STOCKHOLM (Reuters) - A French scientist who shared this year's Nobel prize for medicine said on Saturday he believed the transmission of AIDS could be eliminated within years... full article of Reuters

2008.10.22. Genetic Immunity gave a Plenary Lecture at the 2nd Europe INNOVA Conference
Dr Julianna Lisziewicz, president of Genetic Immunity gave a Plenary Lecture at the 2nd Europe INNOVA Conference is organized by the French Presidency of the European Union in close collaboration with the European Commission (DG Enterprise & Industry) and hosted by the city of Lyon. The conference addressed policy priorities for accelerating innovation in Europe with particular focus on the role of research-driven innovation and knowledge transfer, the role of strategic partnerships in strengthening industry's innovation capacity and the mechanisms for supporting innovative SMEs and entrepreneurs.
Go to homepage of INNOVA Conference... or Download the presentation (in PDF format)

2008.07.13. Genetic Immunity to Present at 2008 BIO International Convention
The Forbes and other important media reported about Genetic Immunity to present at 2008 BIO International Convention. See the articles below: Forbes (06.13.08) - 2008 BIO International Convention Exhibitot Profiles, Forbes (06.12.08), Reuters (06.12.08).

2008.01.22. Zsolt Lisziewicz, Chief Operating Officer of Genetic Immunity is invited as speaker to the BioData Forum in Geneva (Visit website: www.biodataforum.com)

2007.10.08. The "2nd Annual Meeting of Vaccine Therapy Cluster (VTC)" will be at Matrahaza, October 24-27, 2007. The program can be downloaded from here...

2007.09.28. "GlaxoSmithKline cancer vaccine 'impressive'" published by DrugResearcher.com

2007.09.22. "The Final HIV vaccine press release from Merck." Click here to read this document...

2007.09.21. "Statement: Immunizations Are Discontinued in Two HIV Vaccine Trials" published by NIH. Click here to read the full article..

2007.09.18. "Cancer Vaccines Begin to Show Promise" published in THE WALL STREET JOURNAL.

2007.08.30. China and HIV - A Window of Opportunity To read this article in "The NEW ENGLAND JOURNAL of MEDICINE", click here...

2007.08.10. "Nanochemistry-Based Immunotherapy for HIV-1" is the new article of Prof. Julianna Lisziewicz. She is publishing in the Bentham Science Publishers. Download the article click here.

2007.08.07. FDA approves new AIDS drug - can read the article on the USA Today webpage: www.usatoday.com

2007.07.18. Dr. Julianna Lisziewicz, Chair of the Vaccine Therapy Cluster, is invited as speaker on the 15th International Congress of the Hungarian Society of Microbiology which will take place on July 18 - 20 in Budapest (Download: Program of Congress and Second Circular and General info. Or visit website: www.mmt.org.hu)

2007.07.14. Quality scientific publications in Dermatology Open Journals (Bentham Scientific Publishers) See in details...

2007.06.25. The European Commission has published the second FP7 call for proposals.
Identifier: FP7-HEALTH-2007-B
Publication date: 19 June 2007
Deadline: 18 September 2007 at 17:00:00 (Brussels local time)
OJ Reference: OJ C135 of 19 June 2007
Additional information on the Health research call can be found under cordis.europa.eu

2007.06.12. The following articles have been published about the "1st International Symposium on Genetic and Immune Correlates of HIV Infection and Vaccine-Induced Immunity" conference: VG.hu, Origo.hu, Pride.hu, Hirado.hu, WebOrvos.hu, Pozitiv.org.hu, www.masok.hu, hivpozitiv.extra.hu, www.medimagister.hu, www.hirado.hu, EScience.hu (in English).

2007.06.10. 1st International Symposium on Genetic and Immune Correlates of HIV Infection and Vaccine-Induced Immunity 10-13 June, 2007. Budapest, Hungary. VTC (J. Lisziewicz) and Semmelweis University (G. Füst) are coorganizing the conference.
For more information visit page www.hiv-correlates2007.hu

2007.05.19. Interview on NPR with Dr. Anthony Fauci on the progress on prophylactic HIV vaccines Listen the interview here...

2007.04.16. Zsolt Lisziewicz and Csilla Nemes of Genetic Immunity have attended at Semmering Conference 2007. hosted by Vienna Vaccines.

2007.03.09. Article entitled "Magyarországra még vár a tudomány, de kire vár Magyarország?" has been published in magyaronline.net. Click here to read the article.

2007.01.22. Recommendation of the Parliamentary Assembly of the Council of Europe:
"...address the development and testing of medicines specifically for use in children living with HIV, and new technologies such as microbicides and HIV/AIDS vaccines" (click here...)

2006.11.22. Intensive workshop on the project and on future progress of the atherosclerosis group (Programme)

2006.11.10. On invitation of Prof. Julianna Lisziewicz Dr. Arya Suresh from USA visited us and held a successful seminar (Source)

2006.10.12. A new article has been written in the Hungarian online news [origo]egészség. Click here to read the article

2006.06.12. Dr. Julianna Lisziewicz, Chair of the Vaccine Therapy Cluster is invited as speaker to the AIDS Vaccine 2006 Conference which will take place on August 29 - September 1, 2006 in Amsterdam, The Netherlands. Her presentation title is "DermaVir patch therapeutic vaccine in chronic HIV infection: from the concept to the clinic".
And the reaction:

Subject: Letter of thanks

Amsterdam, October 10 2006

Ref: 06-102 / 1217 - AIDS Vaccine 2006 Conference

Dear Mrs. Lisziewicz,

On behalf of the Organizing Committee, I sincerely thank you for your significant presentation during the AIDS Vaccine 2006 Conference in Amsterdam. We are very happy with the many positive reactions we received after the conference and with the number of participans who attended: nearly 1000, of which nearly fifty percent from developing countries.

Thank you again for your contribution, and I hope to see you in Seattle in 2007!

With kind regards,

Joep Lange
Chair, AIDS Vaccine 2006 Conference
Executive Director, Center for Poverty-related Communicable Diseases
Academic Medical Center, University of Amsterdam, the Netherlands

2006.06.12. Dr. Zsolt Lisziewicz, CEO of Genetic Immunity Kft. is invited to the Life Sciences Partnering China & Europe Programme which will take place on Sept. 18-19 in Beijing, China. Meetings with chinese vaccine development companies and leading CDC (Center of Desease Control) officers are planned as well.

2006.07.31. Radio report of Dr. Julianna Lisziewicz to the Info Radio and also released in Magyar Nemzet Online.

2006.06.20. In the monthly publication of Semmelweis University Kata Tolnai reported about the VTC cluster (source: Semmelweis Egyetem újság 2006/7.)

2006.06.12. Eszter Berzsenyi of Genetic Immunity starts one week visit to RIGHT Italy. She will work under the supervision of Prof. Franco Lori. The goal of her trip is to learn the biological assays characterizing the DermaVir Patch product and transfer these assays to the new Budapest laboratories of Genetic Immunity.

2006.05.30. Prof. Julianna Lisziewicz, the leader of the Vaccine Therapy Cluster, has visited IATEC in Amsterdam to establish collaboration.

2006.05.26. Prof. Julianna Lisziewicz, the leader of the Vaccine Therapy Cluster, has visited RIGHT to oversee the collaborative research progress between Genetic Immunity and RIGHT.

2006.05.24. Prof. Julianna Lisziewicz, the leader of the Vaccine Therapy Cluster, has visited Karolinska Institute in Stockholm to establish collaboration.

2006.05.17. The Second Management Committee Meeting took place in the Chemical Research Center, Budapest. There was discussion about the scientific progress, the patent and process development issues, ISO operating procedures. CRC team leaders presented excellent progress in vaccine chemistry. Leaders of VTC with Solvo defined the short, medium and long-term business development focus.

2006.05.02. Dr. Eszter Ujhelyi of St Laszlo Hospital starts one week visit to RIGHT Italy. She will work under the supervision of Prof Franco Lori and Dr. Sandra Calarotta. The goal of her visit is to learn the ELISPOT and Cultured-ELISPOT assay and establish these assays in the clinical immune diagnostic laboratory of Laszlo Hospital.

2006.03.16. The 3 days long VTC kick-off-meeting was held in Mátraháza at the Hungarian Academy of Science Conference Center. Ca 50 participants of the VTC was present. Experienced team leaders gave overview on their research activities and all the specific VTC projects were reviewed. Experimental designs were optimized. Some of the foreign collaborators of the VTC were also present from RIGHT Italy and RIMS Belgium. After the meeting, Dr. Sandra Calarotta from the USA was visiting University Szeged and University Semmelweis to transfer the DermaVir immunization technology in the mice model. She also spent time at Laszlo Hospital to discuss the immunological assays to be established for DermaVir vaccinated human subjects. It was the beginning of a beautiful friendship...

Created by L&Mark Informatika Kft.